Rafael (NYSE:RFL) Stock Price Down 2.4% – Here’s What Happened

Shares of Rafael Holdings, Inc. (NYSE:RFL) were down 2.4% during mid-day trading on Thursday . The company traded as low as $1.80 and last traded at $1.84. Approximately 6,243 shares traded hands during trading, a decline of 79% from the average daily volume of 29,908 shares. The stock had previously closed at $1.88.

Rafael Stock Up 1.9 %

The stock has a market cap of $45.90 million, a PE ratio of -1.10 and a beta of 1.15. The firm has a 50-day simple moving average of $1.99 and a 200-day simple moving average of $1.88.

Rafael (NYSE:RFL) last announced its quarterly earnings results on Thursday, March 13th. The company reported ($0.06) earnings per share (EPS) for the quarter. The firm had revenue of $0.08 million during the quarter. Rafael had a negative return on equity of 53.71% and a negative net margin of 5,707.03%.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Rafael stock. Geode Capital Management LLC boosted its holdings in Rafael Holdings, Inc. (NYSE:RFL) by 24.8% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 148,068 shares of the company’s stock after acquiring an additional 29,448 shares during the quarter. Geode Capital Management LLC owned 0.60% of Rafael worth $287,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 11.30% of the company’s stock.

Rafael Company Profile

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.